Europe close: Stocks give back early gains
23rd Nov 2020 17:23
(Sharecast News) - European shares pared early gains on Monday even after positive news around AstraZeneca's Covid-19 vaccine.
Read moreProof of Covid-19 vaccination may be required for travel, says Qantas
23rd Nov 2020 14:05
(Sharecast News) - International passengers will only be able to travel on Qantas flights if they have been vaccinated against Covid-19, the airline's chief executive has suggested.
Read moreMonday broker round-up
23rd Nov 2020 13:28
(Sharecast News) - DWF Group: Liberum initiates at hold with a target price of 90p.
Read moreAstraZeneca Covid-19 vaccine proves effective
23rd Nov 2020 07:02
(Sharecast News) - AstraZeneca said its Covid-19 vaccine was highly effective in preventing the virus and that it would move quickly to get approval for use.
Read moreUnions call for frontline workers to have priority access to Covid-19 vaccine
20th Nov 2020 08:22
(Sharecast News) - UK unions called for key frontline workers to be given priority access for a Covid-19 vaccine once its rolled out after they were omitted from the list.
Read moreAstraZeneca gets US approval for additional Imfinzi dosing option
20th Nov 2020 07:33
(Sharecast News) - AstraZeneca announced on Friday that 'Imfinzi', or durvalumab, has been approved in the US for an additional dosing option - a 1,500mg fixed dose every four weeks in the approved indications of unresectable stage-3 non-small cell lung cancer after chemoradiation therapy, and previously-treated advanced bladder cancer.
Read moreBerenberg stays at 'buy' on AstraZeneca, positive on antibody treatment
19th Nov 2020 11:10
(Sharecast News) - Analysts at Berenberg struck a positive note on AstraZeneca shares after the drugmaker published full immunogenicity data earlier in the session for its Covid-19 vaccine candidate, AZD 1222.
Read moreAstraZeneca vaccine shows promise among elderly
19th Nov 2020 09:13
(Sharecast News) - AstraZeneca's potential Covid-19 vaccine showed a strong immune response in older people, suggesting it may protect some of those most susceptible to the virus, trial data showed.
Read morePfizer Covid-19 vaccine more than 94% effective in older adults
18th Nov 2020 12:09
(Sharecast News) - The Covid-19 vaccine candidate being developed by Pfizer and BioNTech has shown an elevated degree of efficacy in preventing Covid-19 among those aged 65 and over.
Read moreEurope close: Stocks finish week on up note, despite remaining risks
13th Nov 2020 18:41
(Sharecast News) - European shares finished a week of rampant gains on a positive note, helped by reports that the second wave of Covid-19 cases in Belgium and France might be breaking.
Read moreRising Covid-19 positivity rates in US may require restrictions in large-population states
13th Nov 2020 13:54
(Sharecast News) - Covid-19 test positivity is increasing rapidly and may necessitate that most large-population states impose more severe restrictions, a top-ranked US economist said.
Read moreHSBC upgrades AstraZeneca on vaccine newsflow
11th Nov 2020 11:19
(Sharecast News) - HSBC upgraded AstraZeneca to 'hold' based on stronger commercial delivery and expected further good news about Covid-19 vaccines.
Read moreUK to have 10m doses of Pfizer/BioNTech Covid-19 vaccine by end-2020, if approved
10th Nov 2020 11:06
(Sharecast News) - Britain will have 10m doses of the Covid-19 vaccine being developed by Pfizer and BioNTech by the end of 2020.
Read moreAstraZeneca sees positive results from asthma treatment trial
10th Nov 2020 07:37
(Sharecast News) - AstraZeneca, alongside its partner Amgen, announced positive results from the 'NAVIGATOR' phase 3 trial for the potential new medicine 'tezepelumab' on Tuesday, in patients with severe, uncontrolled asthma.
Read moreAstraZeneca's Calquence receives EU approval
9th Nov 2020 08:38
(Sharecast News) - Pharmaceutical giant AstraZeneca's leukaemia treatment has received European Union approval.
Read more